10-(4-Chlorophenyl)-5,5-difluoro-2,8-diiodo-1,3,7,9-tetramethyl-5H-dipyrrolo[1,2-c:2',1'-f][1,3,2]diazaborinin-4-ium-5-uide, 98%, 100mg

3-bromooxolane-2,4-dione, 98%, 5g

N,N-Dimethyl-1H-imidazole-1-sulfonamide>98.0%(GC)1g

1-Methyl-6-oxo-1,6-dihydropyridine-2-carboxylic acid, 95.0%, 25g

(6-Methoxy-2-methylsulfanyl-pyrimidin-4-yl)-piperidin-4-yl-amine hydrochloride, 95.0%, 100mg

6-Bromo-N-(3,4,5-trimethoxyphenyl)-4-quinolinamine, 98%, 50mg

2-Methyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydroisoquinolin-1(2H)-one, 98%, 1g

Objectif Plan PLPOLi 60x/0,85 IOS sans contrainte pour polarisation transmise iScope, correction du verre de protection de 0,17 mm, distance de travail de 0,14 mm

2-(Prop-2-yn-1-yloxy)acetic acid, 97%, 250mg

1-((4S,5S)-2,2-dimethyl-5-vinyl-1,3-dioxolan-4-yl)-2-(trityloxy)ethanone, 98%, 500mg

Ciclopirox, 97.0%, 5g

3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazolo[1,5-a]pyrimidine, 95.0%, 100mg

Capsazepine, >99%, 10mg